94 results
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
8 Jan 24
Regulation FD Disclosure
7:45am
-3x 1 Nelson et al., 2015 (Nature Genetics); King et al., 2019 (PLOS Genetics). 2 https://www.astrazeneca.com/content/dam/az/PDF/2017/Q3/Year
8-K
EX-99.2
ME
23andMe Holding Co - Ordinary Shares
8 Jan 24
Regulation FD Disclosure
7:45am
in the World *Publications supporting human genetic evidence for approved drug indications Nelson et al., 2015 (Nature Genetics); King et al., 2019 … likely to succeed1 2x-3x Nelson et al., 2015 (Nature Genetics); King et al., 2019 (PLOS Genetics)
9Copyright © 2024 23andMe, Inc. SNPs are tested across
8-K
EX-10.1
321qoalcpj1
27 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
tk8fo2 37
10 Oct 23
Regulation FD Disclosure
4:17pm
S-8
EX-99.1
o3f96r547zg3
15 Sep 23
Registration of securities for employees
4:06pm
DEFR14A
2543kjcjgftvyn0z
4 Aug 23
Revised proxy
4:05pm
DEFR14A
gzn4qia
26 Jul 23
Revised proxy
9:14pm
8-K
EX-99.1
yj9il0n9
17 Apr 23
Regulation FD Disclosure
4:10pm
8-K
EX-10.1
d5zmol8v63n7
9 Dec 22
Departure of Directors or Certain Officers
8:05am
8-K
EX-99.1
o4wx1c
9 Nov 22
Investor Presentation November 2022
7:30am
424B3
i31nqjs
7 Nov 22
Prospectus supplement
4:33pm
8-K
EX-99.1
mot6dmrsepj
18 Aug 22
Investor Presentation August 2022
4:06pm
424B3
nl5jhq
16 Aug 22
Prospectus supplement
6:12pm